|Daily Wellness||Diet & Fitness||Diseases & Conditions||Health Channels||Health News||Health Tools|
Topics in Health News
After FDA Approval, Allergan Ready To Sell Drug For EyelashesThis article has been read 5 times
Boston (dbTechno) - Allergan Inc. is getting ready to sell their glaucoma drug Lumigan for the purpose of enhancing the appearance of your eyelashes.
The U.S. Food and Drug Administration (FDA) has given approval to the glaucoma drug to be used cosmetically.
The drug is going to be marketed under the brand name of Latisse.
The drug will be used to treat a condition known as hypotrichosis.Â This occurs in people who have a hard time growing eyelashes.
The idea behind the drug, once launched, is to help build up longer, thicker eyelahes in people.
The FDA approval is for the drug to be taken once each day, and is expected to be released in Q1.
This is a prescription drug, and was found to be highly successful in trials conducted.
An FDA panel recently gave a unanimous approval to approving the drug for this use.
About FullHealth.net |
Sponsor Policy |
Site Map |
Link to Us |
Contact Us |
©2008-2009 FullHealth.net All rights reserved.